| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.12(B) |
| Last
Volume: |
7,714,820 |
Avg
Vol: |
8,368,014 |
| 52
Week Range: |
$48.64 - $77.71 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
421,705 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$30,048,564 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
25 |
43 |
79 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2008-11-18 |
4 |
S |
$7.15 |
$715,400 |
I/I |
(100,000) |
29,456,977 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-11-18 |
4 |
S |
$7.26 |
$2,572,302 |
I/I |
(353,900) |
29,556,977 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
– • – |
2008-11-18 |
4 |
B |
$7.34 |
$73,400 |
I/I |
10,000 |
110,000 |
2.1 |
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-11-17 |
4 |
S |
$7.38 |
$1,475,000 |
I/I |
(200,000) |
29,910,877 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-11-14 |
4 |
S |
$7.85 |
$36,110 |
I/I |
(4,600) |
30,110,877 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2008-10-31 |
4 |
B |
$7.15 |
$11,440 |
D/D |
1,600 |
18,417 |
2.74 |
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2008-10-31 |
4 |
D |
$9.03 |
$7,585 |
D/D |
(840) |
23,598 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2008-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,645 |
24,438 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2008-10-31 |
4 |
D |
$9.03 |
$18,638 |
D/D |
(2,064) |
28,828 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2008-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
30,892 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2008-10-31 |
4 |
D |
$9.03 |
$18,638 |
D/D |
(2,064) |
16,817 |
|
- |
|
| Kucheman William |
SVP & Group President |
• – – |
2008-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
18,881 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2008-10-30 |
4 |
D |
$8.71 |
$6,480 |
D/D |
(744) |
9,235 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2008-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
9,979 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2008-10-30 |
4 |
D |
$8.71 |
$25,808 |
D/D |
(2,963) |
21,793 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2008-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,332 |
24,756 |
|
- |
|
| Groves Ray J |
Director |
– • – |
2008-10-30 |
4 |
B |
$8.71 |
$69,992 |
I/I |
8,000 |
1,000 |
2.1 |
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-29 |
4 |
S |
$8.05 |
$483,007 |
I/I |
(60,000) |
30,115,477 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-28 |
4 |
S |
$6.92 |
$15,173,850 |
I/I |
(2,150,000) |
30,175,477 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-28 |
4 |
S |
$7.12 |
$6,411,600 |
D/D |
(900,000) |
14,402,846 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2008-10-28 |
4 |
B |
$7.39 |
$110,936 |
D/D |
15,000 |
88,804 |
2.39 |
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-27 |
4 |
S |
$7.47 |
$7,600,500 |
I/I |
(1,000,000) |
32,325,477 |
|
- |
|
| Groves Ray J |
Director |
– • – |
2008-10-24 |
4 |
B |
$8.20 |
$82,040 |
D/D |
10,000 |
29,167 |
2.39 |
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-23 |
4 |
S |
$8.24 |
$8,489,981 |
I/I |
(1,030,400) |
33,325,477 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-22 |
4 |
S |
$8.66 |
$7,794,000 |
I/I |
(900,000) |
34,355,877 |
|
- |
|
1823 Records found
|
|
Page 62 of 73 |
|
|
0.01 (0.01%) 
